Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Substance Withdrawal Syndrome × Naltrexone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Obesity 3 Breast Neoplasms 3 Overweight 2 Substance Withdrawal Syndrome 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Metabolic Syndrome 1 Melanoma 1 Inflammation 1 Glioma 1 Glioblastoma 1 Dyslipidemias 1 Chronic Pain 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

nilotinib 1 morphine, naltrexone combination 1 Naltrexone 1 Morphine 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01100437 2012-07-13

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Pfizer

Phase 4 Terminated

14 enrolled 18 charts

Substance Withdrawal Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡